Venus Remedies bags contract to supply anti-cancer drug to Thailand
September 28th, 2010 - 9:09 pm ICT by IANSChandigarh, Sep 28 (IANS) Venus Remedies has won a contract worth over Rs.100 million to supply its anti-cancer drug to the government of Thailand, a company spokesperson said here Tuesday.
The drug, Docetaxel, will be supplied to the Government Pharmaceutical Organization (GPO) under Thailand’s ministry of health. The contract has been awarded through the scheme of Compulsory License issued by the GPO.
The GPO, after importing the drug, would make it available amongst poor who cannot afford high cost anti-cancer drugs.
“The contract is valid for one year and is expected to generate a business of more than Rs.100 million to the company,” said Venus Remedies Chairman and Managing Director Pawan Chaudhary.
“We have tied up with a local pharmaceutical group for marketing and distribution of the product in the entire Thai market. The supply of this product will begin by November 2010,” he said.
- Panacea Biotec commissions anti-cancer unit in Himachal - Mar 29, 2012
- Drug firm Strides to buy out Aspen stake in JVs - Mar 18, 2010
- Jubilant inks $80 mn contract with global firm - Aug 12, 2011
- Dabur to supply anti-cancer drug to Thailand - Apr 09, 2008
- Thailand seeks Indian investments - Jan 25, 2012
- Gujarat firm to produce nausea preventing nasal spray - Jan 18, 2011
- Dr.Reddy's acquires JB Chemicals business in Russia - Jul 23, 2011
- Ranbaxy boosts presence in Africa with malaria drug - May 11, 2012
- Cuba showcases cancer vaccines - Mar 06, 2012
- High dose of oxygen boosts natural cancer treatment - Apr 05, 2011
- Arms suppliers cashing on offset clause face challenges - Mar 17, 2012
- Obama takes action to reduce medicine scarcity - Nov 01, 2011
- Cuba working on anti-cancer treatment using scorpion venom - Nov 30, 2011
- Ranbaxy's South African arm bags $133 million order - Dec 20, 2010
- Himachal official convicted in graft case - Jun 28, 2011
Tags: 100 million, cancer drug, cancer drugs, chandigarh, company spokesperson, compulsory license, contract worth, docetaxel, government of thailand, gpo, managing director, marketing, ministry of health, pharmaceutical group, pharmaceutical organization, thai market